Pretreatment with ticagrelor may offset additional inhibition of platelet and coagulation activation with bivalirudin compared to heparin during primary percutaneous coronary intervention

Autor: Venetsanos, Dimitrios, Lindahl, Tomas L., Lawesson, Sofia Sederholm, Gustafsson, Kerstin M., Wallen, Håkan, Erlinge, David, Swahn, Eva, Alfredsson, Joakim
Zdroj: In Thrombosis Research November 2018 171:38-44
Databáze: ScienceDirect